TRPC6-IN-3

TRPC6-IN-3 (compound 17) is a potent, orally active transient receptor potential C6 ion channel (TRPC6) inhibitor. TRPC6-IN-3 modulates not only intracellular calcium concentration, but also membrane potential by modulating the flux of cations including calcium and sodium ions. TRPC6-IN-3 can be used in research of respiratory system. In Vivo TRPC6-IN-3 (compound 17; 1-10 mg/kg; p.o.; orally 12 h and 2 h before LPS challenge; LPS-induced mice) inhibits LPS-induced vascular leakage and inhibits accumulation of Broncho-Alveolar-Lavage protein (BALF protein) in a mouse model . TRPC6-IN-3 (3 mg/kg; p.o.; daily, for 4 d; H1N1-induced mice) reduces H1N1-induced vascular leakage in a mouse model . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: LPS-induced mice Dosage: 1, 3, and 10 mg/kg Administration: Oral administration; orally 12 h and 2 h before LPS challenge Result: Reduced BALF protein concentration of 56 % at 3 mg/kg and 62 % at 10 mg/kg. Animal Model: H1N1-induced mice Dosage: 3 mg/kg Administration: Oral administration; daily, for 4 days Result: Inhibited Evans blue extravasation from the blood to the BALF and reduced BALF Evans blue by 24 % at 3 mg/kg. Form:Solid

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet